US FDA clears Mabwell’s IND application to initiate phase IIa study of novel anti-ST2 monoclonal antibody, 9MW1911 to treat moderate-to-severe COPD: Shanghai Monday, December 29 ...

Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...

Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing novel small molecule therapeutics to treat ...

A new study suggests that adding cannabidiol, commonly known as CBD, to products containing caffeine and ...

Microbes often display cooperative behavior in which individual cells put in work and sacrifice resources to collectively ...

AR and arctiin have been extensively studied for their anti-inflammatory effects in both in vitro and in vivo models. Inflammation is a series of protective responses of the body against exogenous ...

Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...

A physiologically based pharmacokinetic (PBPK) model developed for suraxavir marboxil (GP681) and its active metabolite GP1707D07 quantitatively predicts clinically relevant drug–drug interactions ...

One in four people globally live in a country whose population has already peaked in size. 11 July 2024 - According to the World Population Prospects 2024: Summary of Results published today, it is ...

Phase 3 Topline Results for Potential Best-in-Class Regimen for Treatment of HCV on Track for 2026Topline Results from North American Phase 3 ...

Genetic conditions with actionable interventions affect nearly 10% of populations in the United States and internationally - ...

Tesla Model Y is an all-electric compact SUV built on Tesla's third-generation vehicle platform. As the newest EV to hit roads for Tesla, the Model Y CUV continues to grow in popularity as a more ...